Fig. 4From: Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxabanComparison of miR-320a (A) and miR-483 (B) level between 3 and 0 h in the 15 mg fasted case groupBack to article page